Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram- negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1377-1379

  Boswell, F J ^a   Andrews, J M ^a   Wise, R ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4,3,0]NON 8 YL) 6 FLUORO 8 METHOXY 1,4 DIHYDRO 4 OXO 3 QUINOLINE; CEFOXITIN; METRONIDAZOLE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEROIDES FRAGILIS; CONTROLLED STUDY; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

EID: 0030943901     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1377     Document Type: Article

References (13)

1. Boswell, F. J., J. M. Andrews, and R. Wise. 1996. Bactericidal activity of trovafloxacin under anaerobic and aerobic conditions. Infect. Dis. Clin. Pract. 5(Suppl. 3):5113-5116.
2. Cooper, M. A., J. M. Andrews, and R. Wise. 1991. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions. J. Antimicrob. Chemother. 28:399-405.
3. Craig, W. A., and S. Gudmundsson. 1991. Postantibiotic effect, p. 403-431. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. Williams & Wilkins, Baltimore, Md.
4. Dalhoff, A., U. Peterson, and R. Endermann. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemotherapy, in press.
5. Griggs, D. J., L. J. V. Piddock, and R. Wise. 1989. The killing action of fleroxacin upon Bacteroides fragilis. J. Antimicrob. Chemother. 23:53-58.
6. Hyatt, J. M., D. E. Nix, C. W. Stratton, and J. J. Schentag. 1995. In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1711-1716.
7. Lewin, C. S., I. Morrissey, and J. T. Smith. 1992. The bactericidal activity of sparfloxacin. J. Antimicrob. Chemother. 30:625-632.
8. Miles, A. A., and S. S. Misra. 1938. The estimation of the bactericidal power of the blood. J. Hyg. 38:732-740.
9. Morrissey, I., C. S. Lewin, and J. T. Smith. 1990. The influence of oxygen upon bactericidal potency, p. 23-36. In G. C. Crumplin (ed.). The quinolones: antibacterial agents in vitro. Springer-Verlag, London, United Kingdom.
10. Morrissey, I., and J. T. Smith. 1990. PD127,391-2: a 4-quinolone bactericidal under anaerobic conditions, abstr. 377, p. 149. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. National Committee for Clinical Laboratory Standards. 1992. Methods for determining bactericidal activity of antimicrobial agents. Tentative guidelines. National Committee for Clinical Laboratory Standards document M26-T, vol. 12. no. 19. National Committee for Clinical Laboratory Standards, Villanova, Pa.
12. Working Party of the British Society for Antimicrobial Chemotherapy. 1991. A guide to sensitivity testing. J. Antimicrob. Chemother. 27(Suppl. D):22-30.
13. Zabinski, R. A., K. J. Walker, A. J. Larsson, J. A. Moody, G. W. Kaatz, and J. C. Rotschafer. 1995. Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones. Antimicrob. Agents Chemother. 39:507-512.